Carnitine deficiency increases susceptibility to bupivacaine-induced cardiotoxicity in rats

Anesthesiology

Volumn 114, Issue 6, 2011, Pages 1417-1424

  Wong, Gail K ^a   Crawford, Mark W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CARNITINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASYSTOLE; CARDIOTOXICITY; CARNITINE DEFICIENCY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 79958125199     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31821a8d46     Document Type: Conference Paper

References (50)

1. Mulroy MF: Systemic toxicity and cardiotoxicity from local anesthetics: Incidence and preventive measures. Reg Anesth Pain Med 2002; 27:556-61. (Pubitemid 35387142)
2. Levsky ME, Miller MA: Cardiovascular collapse from low dose bupivacaine. Can J Clin Pharmacol 2005; 12:e240-5. (Pubitemid 43097166)
3. Wong GK, Joo DT, McDonnell C: Lipid resuscitation in a carnitine deficient child following intravascular migration of an epidural catheter. Anaesthesia 2010; 65:192-5.
4. Weinberg GL, Laurito CE, Geldner P, Pygon BH, Burton BK: Malignant ventricular dysrhythmias in a patient with isovaleric acidemia receiving general and local anesthesia for suction lipectomy. J Clin Anesth 1997; 9:668-70. (Pubitemid 28020988)
5. Mayes PA: Oxidation of fatty acids: Ketogenesis, Harper's Biochemistry, 25th edition. Edited by Murray RK, Granner DK, Rodwell VW. New York, McGraw-Hill Medical Publishers, 2000, pp 238-49.
6. Weinberg GL, Palmer JW, VadeBoncouer TR, Zuechner MB, Edelman G, Hoppel CL: Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. ANESTHESIOLOGY 2000; 92: 523-8. (Pubitemid 30078352)
7. Eledjam JJ, de La Coussaye JE, Brugada J, Bassoul B, Gagnol JP, Fabregat JR, Massé C, Sassine A: In vitro study on mechanisms of bupivacaine-induced depression of myocardial contractility. Anesth Analg 1989; 69:732-5. (Pubitemid 20041775)
8. Sztark F, Malgat M, Dabadie P, Mazat JP: Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics. ANESTHESIOLOGY 1998; 88:1340-9. (Pubitemid 28216879)
9. de La Coussaye JE, Bassoul B, Albat B, Peray PA, Gagnol JP, Eledjam JJ, Sassine A: Experimental evidence in favor of role of intracellular actions of bupivacaine in myocardial depression. Anesth Analg 1992; 74:698-702.
10. Irwin W, Fontaine E, Agnolucci L, Penzo D, Betto R, Bortolotto S, Reggiani C, Salviati G, Bernardi P: Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem 2002; 277:12221-7. (Pubitemid 34952789)
11. Paulson DJ, Shug AL: Tissue specific depletion of L-carnitine in rat heart and skeletal muscle by D-carnitine. Life Sci 1981; 28:2931-8. (Pubitemid 11043977)
12. Tsoko M, Beauseigneur F, Gresti J, Niot I, Demarquoy J, Boichot J, Bezard J, Rochette L, Clouet P: Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a gamma-butyrobetaine hydroxylase inhibitor. Biochem Pharmacol 1995; 49: 1403-10.
13. Spaniol M, Brooks H, Auer L, Zimmermann A, Solioz M, Stieger B, Krähenbühl S: Development and characterization of an animal model of carnitine deficiency. Eur J Biochem 2001; 268:1876-87.
14. Al-Majed AA, Sayed-Ahmed MM, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA: Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res 2006; 53: 278-86. (Pubitemid 43247541)
15. Onem G, Aral E, Enli Y, Oguz EO, Coskun E, Aybek H, Ozcan AV, Sacar M, Bir LS, Baltalarli A, Baycu C: Neuroprotective effects of L-carnitine and vitamin E alone or in combination against ischemia-reperfusion injury in rats. J Surg Res 2006; 131:124-30. (Pubitemid 43227594)
16. Marzo A, Cardace G, Corbelleta C, Bassani E, Morabito E, Arrigoni Martelli E: Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats. Eur J Drug Metab Pharmacokinet 1991; Spec No 3:357-63.
17. Suzuki Y, Kamikawa T, Yamazaki N: Effect of L-carnitine on cardiac hemodynamics. Jpn Heart J 1981; 22:219-25. (Pubitemid 11106166)
18. Russell S: Carnitine as an antidote for acute valproate toxicity in children. Curr Opin Pediatr 2007; 19:206-10. (Pubitemid 46668075)
19. Lheureux PE, Penaloza A, Zahir S, Gris M: Science review: Carnitine in the treatment of valproic acid-induced toxicity: What is the evidence? Crit Care 2005; 9:431-40. (Pubitemid 41498538)
20. Ohmura S, Kawada M, Ohta T, Yamamoto K, Kobayashi T: Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats. Anesth Analg 2001; 93:743-8. (Pubitemid 32783305)
21. St Louis P, Das I, Rybczynski J, Bissonnette B, Hartley EJ: Determination of bupivacaine in plasma by high-performance liquid chromatography. Levels after scalp infiltration in children. Clin Biochem 1991; 24:463-7.
22. Galan A, Padros A, Arambarri M, Martin S: Automation of a spectrophotometric method for measuring L-carnitine in human blood serum. J Automat Chem 1998; 20:23-6.
23. Harper P, Elwin CE, Cederblad G: Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol 1988; 35:555-62. (Pubitemid 18264762)
24. Stanley CA, Bennett MJ: Disorders of mitochondrial fatty acid beta-oxidation, Nelson Textbook of Pediatrics, 17th Edition. Edited by Behrman RE, Kliegman RM, Jenson HB. Philadelphia, Elsevier Science Publishers, 2003, pp 567-71.
25. Pons R, Carrozzo R, Tein I, Walker WF, Addonizio LJ, Rhead W, Miranda AF, Dimauro S, De Vivo DC: Deficient muscle carnitine transport in primary carnitine deficiency. Pediatr Res 1997; 42:583-7. (Pubitemid 27459462)
26. Tein I: Carnitine transport: Pathophysiology and metabolism of known molecular defects. J Inherit Metab Dis 2003; 26: 147-69. (Pubitemid 36889739)
27. Pons R, De Vivo DC: Primary and secondary carnitine deficiency syndromes. J Child Neurol 1995; 10 (Suppl 2):S8-24.
28. Parikh S, Cohen BH, Gupta A, Lachhwani DK, Wyllie E, Kotagal P: Metabolic testing in the pediatric epilepsy unit. Pediatr Neurol 2008; 38:191-5. (Pubitemid 351221228)
29. Raskind JY, El-Chaar GM: The role of carnitine supplementation during valproic acid therapy. Ann Pharmacother 2000; 34:630-8. (Pubitemid 30257492)
30. Stadler DD, Bale JF Jr, Chenard CA, Rebouche CJ: Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans. Metabolism 1999; 48: 74-9. (Pubitemid 29035564)
31. Reiz S, Nath S: Cardiotoxicity of local anaesthetic agents. Br J Anaesth 1986; 58:736-46. (Pubitemid 16098078)
32. Mather LE, Chang DH: Cardiotoxicity with modern local anaesthetics: Is there a safer choice? Drugs 2001; 61:333-42. (Pubitemid 32270042)
33. Clarkson CW, Hondeghem LM: Mechanism for bupivacaine depression of cardiac conduction: Fast block of sodium channels during the action potential with slow recovery from block during diastole. ANESTHESIOLOGY 1985; 62:396-405. (Pubitemid 15111320)
34. Castle NA: Bupivacaine inhibits the transient outward K current but not the inward rectifier in rat ventricular myocytes. J Pharmacol Exp Ther 1990; 255:1038-46.
35. Valenzuela C, Delpón E, Tamkun MM, Tamargo J, Snyders DJ: Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. Biophys J 1995; 69: 418-27.
36. Butterworth JF 4th, Brownlow RC, Leith JP, Prielipp RC, Cole LR: Bupivacaine inhibits cyclic-3′,5′-adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity. ANESTHESIOLOGY 1993; 79:88-95. (Pubitemid 23215153)
37. Rossner KL, Freese KJ: Bupivacaine inhibition of L-type calcium current in ventricular cardiomyocytes of hamster. ANESTHESIOLOGY 1997; 87:926-34. (Pubitemid 27456247)
38. Komai H, Lokuta AJ: Interaction of bupivacaine and tetracaine with the sarcoplasmic reticulum Ca2 release channel of skeletal and cardiac muscles. ANESTHESIOLOGY 1999; 90: 835-43. (Pubitemid 29113705)
39. Weinberg GL: Limits to lipid in the literature and lab: What we know, what we don't know. Anesth Analg 2009; 108: 1062-4.
40. Maresca P, Mancinelli R, Corsico N, Arrigoni-Martelli E, Manni E: Positive action of propionyl-L-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy. Eur J Pharmacol 1995; 287:303-7. (Pubitemid 26005585)
41. Folts JD, Shug AL, Koke JR, Bittar N: Protection of the ischemic dog myocardium with carnitine. Am J Cardiol 1978; 41:1209-14.
42. Kawasaki N, Lee JD, Shimizu H, Ueda T: Long-term L-carnitine treatment prolongs the survival in rats with Adriamycininduced heart failure. J Card Fail 1996; 2:293-9. (Pubitemid 126666368)
43. Ferrari R, Ceconi C, Cargnoni A, Pasini E, Boffa GM, Curello S, Visioli O: The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria. Cardiovasc Drugs Ther 1991; 5 (Suppl 1): 57-65.
44. Winter S, Jue K, Prochazka J, Francis P, Hamilton W, Linn L, Helton E: The role of L-carnitine in pediatric cardiomyopathy. J Child Neurol 1995; 10 (Suppl 2):S45-51.
45. Ferrari R, De Giuli F: The propionyl-L-carnitine hypothesis: An alternative approach to treating heart failure. J Card Fail 1997; 3:217-24.
46. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C: Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: A review. Ann N Y Acad Sci 2004; 1033:79-91. (Pubitemid 39656740)
47. Fukuda H, Hirabayashi Y, Shimizu R, Saitoh K, Mitsuhata H: Sevoflurane is equivalent to isoflurane for attenuating bupivacaine-induced arrhythmias and seizures in rats. Anesth Analg 1996; 83:570-3. (Pubitemid 26296368)
48. Paulson DJ: Carnitine deficiency-induced cardiomyopathy. Mol Cell Biochem 1998; 180:33-41. (Pubitemid 28118801)
49. Winter SC, Buist NR: Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine. Am Heart J 2000; 139:S63-9. (Pubitemid 30091770)
50. Zaugg CE, Spaniol M, Kaufmann P, Bellahcene M, Barbosa V, Tolnay M, Buser PT, Krähenbühl S: Myocardial function and energy metabolism in carnitine-deficient rats. Cell Mol Life Sci 2003; 60:767-75 (Pubitemid 36570767)